cladribine

Poland

Drugs containing this active substance

  • BIODRIBIN

    The medicinal product is intended for the treatment of hematopoietic malignancies: hairy cell leukemia (at all stages), chronic lymphocytic leukemia, and low-grade non-Hodgkin lymphomas that are resistant to other drugs.

    Form: solution for infusion

    Active substance Dosage
    cladribine 10 mg/10 ml

    ATC: L01BB04

    Manufacturer: Łukasiewicz Research Network - Industrial Chemistry Institute named after Prof. Ignacy Mościcki

  • LEUJECT

    The medicine is used for the treatment of hairy cell leukemia.

    Form: solution for injection

    Active substance Dosage
    cladribine 10 mg/5 ml

    ATC: L01BB04

    Manufacturer: Pharma Pack Hungary Kft.